Mekinist 0.5 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MA3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,770
Award facts
- Contract value 100% obligated
- $19,769.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets in a quantity of 30 units, valued at $19,769.64, with an ultimate completion date of February 10, 2026. This non-competitive delivery order leverages AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.99 million through December 2026), which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is headquartered in Conshohocken, Pennsylvania, and serves as a critical pharmaceutical distributor for federal medical procurement needs.
Mekinist is a targeted therapy medication primarily used in oncology treatment protocols, and this delivery order fulfills specific medical supply requirements within the military's healthcare system. The contract was awarded without set-aside restrictions, reflecting AmerisourceBergen's competitive positioning within the federal pharmaceutical distribution market. The company's extensive portfolio of federal contract awards demonstrates its capability to efficiently fulfill government requirements for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains in support of military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F9MA3?
SPE2DR26F9MA3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9MA3 worth?
The government has obligated $19,770 on SPE2DR26F9MA3.
Is contract SPE2DR26F9MA3 an order under another contract?
Yes. SPE2DR26F9MA3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MA3 competed?
The extent of competition for SPE2DR26F9MA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award